Vanguard Global Advisers’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
Vanguard Global Advisers's AMPH Position: Q3 2026 in Review
Vanguard Global Advisers reduced its Amphastar Pharmaceuticals (AMPH) stake by 2.1% in Q3 2026, selling an estimated $39.1K and leaving 85,831 shares worth $2.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1183.
Vanguard Global Advisers first reported a position in AMPH in Q1 2026 and has held it in 3 quarters since. 227 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.
- Vanguard Global Advisers held 85,831 shares of Amphastar Pharmaceuticals worth $2.22M as of Q3 2026.
- Vanguard Global Advisers sold 1,808 Amphastar Pharmaceuticals shares in Q3 2026, an estimated $39.1K.
- Amphastar Pharmaceuticals made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1183 holding.
- Vanguard Global Advisers first reported a position in Amphastar Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- 227 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.